The attorney for a Tennessee man who said he was “hurting so bad” during his lethal injection this week says his implanted ...

The initial CEOR phase could increase output by 2,800 barrels per day (bpd), with production rising to between 30,000 and ...

Pavblu, an Eylea HD biosimilar, shows stable vision outcomes and minimal side effects in real-world use, promising a reliable ...

AstraZeneca said on Thursday its experimental therapy, gefurulimab, met the primary goal and all secondary endpoints in a ...